Scarica l'app Stockscreener
10.58
5.70%
-0.64
Precedente Chiudi:
$11.22
Aprire:
$11.31
Volume 24 ore:
281.98K
Relative Volume:
0.77
Capitalizzazione di mercato:
$572.79M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-2.3611
EPS:
-4.481
Flusso di cassa netto:
-
1 W Prestazione:
-15.63%
1M Prestazione:
+26.56%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$10.18
$11.31
Intervallo di 1 settimana:
$10.18
$12.94
Portata 52W:
$7.90
$16.50
Eikon Therapeutics Inc Stock (EIKN) Company Profile
Nome
Eikon Therapeutics Inc
Settore
Industria
Telefono
341-777-0566
Indirizzo
230 HARRIET TUBMAN WAY, MILLBRAE
Compare EIKN vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EIKN
Eikon Therapeutics Inc
|
10.58 | 572.79M | 0 | 0 | 0 | -4.481 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Eikon Therapeutics Inc Stock (EIKN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-02 | Iniziato | BofA Securities | Buy |
| 2026-03-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2026-03-02 | Iniziato | JP Morgan | Overweight |
| 2026-03-02 | Iniziato | Mizuho | Outperform |
| 2026-03-02 | Iniziato | Morgan Stanley | Overweight |
| 2026-02-26 | Iniziato | Wedbush | Underperform |
Mostra tutto
Eikon Therapeutics Inc Borsa (EIKN) Ultime notizie
Is Eikon Therapeutics, Inc. (EIKN) Stock a Biotech Growth Opportunity Despite Limited Q1 Updates? - Yahoo Finance
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 2000 Index - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS:EIKN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 2000 Value Benchmark - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS:EIKN) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 2000 Growth Benchmark - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 3000E Growth Benchmark - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell Microcap Index - marketscreener.com
Eikon Therapeutics to join Russell 3000 index - MSN
Eikon Therapeutics to Join the Russell 3000 Index - marketscreener.com
Enterprise value to EBITDA forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics เตรียมเข้าคำนวณในดัชนี Russell 3000 หลังการปรับโครงสร้างดัชนีประจำปี - Moomoo
Price to sales forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics, Inc. Actuals & Estimates (NASDAQ:EIKN) - TradingView
Price to book forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics to join Russell 3000 Index on Friday By Investing.com - Investing.com South Africa
Price to earnings forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Enterprise value to EBIT forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Price to book forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Price to sales forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Eikon Therapeutics to join Russell 3000 Index on Friday - Investing.com
Eikon Therapeutics to Join Russell 3000 Index Following Annual Reconstitution - Quiver Quantitative
Eikon Therapeutics to Join the Russell 3000® Index - The Manila Times
EIKN Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Price to earnings forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to S&P Global BMI Index - marketscreener.com
Eikon Therapeutics Ord Shs (EIKN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Eikon Therapeutics Ord Shs (EIKN) Institutional Confidence - TradingKey
Eikon Therapeutics (EIKN) Slips 1.23% as Stock Tests Key Support at $9.13Entry Point Alerts - dars.gov.et
IPO Tracker 2026: Cardio biotech Kardigan binds off $400M upsized IPO - BioSpace
Eikon Therapeutics Ord Shs (EIKN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Eikon Therapeutics: Buy TLR Combinatory Potential Only After Lock-Up Expiry - Seeking Alpha
Soros opened a brand new EIKN position — moomoo's New tab ca...moomoo Community - Moomoo
Eikon Therapeutics: Initiating Coverage With A Cautious Buy Rating (NASDAQ:EIKN) - Seeking Alpha
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Eikon Therapeutics Appoints Ma. Fatima Francisco to Board - The Globe and Mail
New director and stock option grant at Eikon Therapeutics (NASDAQ: EIKN) - Stock Titan
EIKN Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue ChallengesLow Estimate Range - dars.gov.et
Eikon Therapeutics (EIKN) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Eikon Therapeutics discloses new USP1 inhibitors - BioWorld News
Eikon Therapeutics, Inc. Announces Appointment of Ma. Fatima D. Francisco as Independent Director and Compensation Committee Member, Effective June 15, 2026 - marketscreener.com
Eikon Therapeutics appoints Francisco to board of directors By Investing.com - Investing.com Nigeria
Eikon Therapeutics appoints Francisco to board of directors - Investing.com India
Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors - The Manila Times
Eikon Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.8, Implies 158% Upside - TradingView
BofA Securities Maintains Eikon Therapeutics(EIKN.US) With Buy Rating, Cuts Target Price to $32 - Moomoo
Cantor Fitzgerald reiterates Overweight on Eikon stock By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates Overweight on Eikon stock - Investing.com UK
Eikon Therapeutics Inc Azioni (EIKN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):